DK2683684T3 - Fremstilling af et 1-amino-3-hydroxy-cyclobutan-1-carboxylsyrederivat - Google Patents
Fremstilling af et 1-amino-3-hydroxy-cyclobutan-1-carboxylsyrederivat Download PDFInfo
- Publication number
- DK2683684T3 DK2683684T3 DK12707320.3T DK12707320T DK2683684T3 DK 2683684 T3 DK2683684 T3 DK 2683684T3 DK 12707320 T DK12707320 T DK 12707320T DK 2683684 T3 DK2683684 T3 DK 2683684T3
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- formula
- palladium
- catalyst
- amino
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title description 6
- OEQBVNDAVKXWBS-UHFFFAOYSA-N 1-amino-3-hydroxycyclobutane-1-carboxylic acid Chemical class OC(=O)C1(N)CC(O)C1 OEQBVNDAVKXWBS-UHFFFAOYSA-N 0.000 title 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 46
- 150000001875 compounds Chemical class 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 30
- 239000003054 catalyst Substances 0.000 claims description 22
- 229910052763 palladium Inorganic materials 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 239000012429 reaction media Substances 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- -1 t-butoxycarbonyl Chemical group 0.000 claims description 4
- 239000012217 radiopharmaceutical Substances 0.000 description 7
- 229940121896 radiopharmaceutical Drugs 0.000 description 7
- 230000002799 radiopharmaceutical effect Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000006264 debenzylation reaction Methods 0.000 description 5
- NTEDWGYJNHZKQW-KWCOIAHCSA-N 1-amino-3-fluoranylcyclobutane-1-carboxylic acid Chemical compound OC(=O)C1(N)CC([18F])C1 NTEDWGYJNHZKQW-KWCOIAHCSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940027541 fluciclovine f-18 Drugs 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 238000002600 positron emission tomography Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000000032 diagnostic agent Substances 0.000 description 3
- 229940039227 diagnostic agent Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- NTEDWGYJNHZKQW-DGMDOPGDSA-N fluciclovine ((18)F) Chemical compound OC(=O)[C@]1(N)C[C@H]([18F])C1 NTEDWGYJNHZKQW-DGMDOPGDSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000009206 nuclear medicine Methods 0.000 description 3
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- KRHYYFGTRYWZRS-BJUDXGSMSA-M fluorine-18(1-) Chemical compound [18F-] KRHYYFGTRYWZRS-BJUDXGSMSA-M 0.000 description 2
- 230000004153 glucose metabolism Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- AOYNUTHNTBLRMT-MXWOLSILSA-N 2-Deoxy-2(F-18)fluoro-2-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H]([18F])C=O AOYNUTHNTBLRMT-MXWOLSILSA-N 0.000 description 1
- 108050005273 Amino acid transporters Proteins 0.000 description 1
- 102000034263 Amino acid transporters Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZCXUVYAZINUVJD-GLCXRVCCSA-N [18F]fluorodeoxyglucose Chemical compound OC[C@H]1OC(O)[C@H]([18F])[C@@H](O)[C@@H]1O ZCXUVYAZINUVJD-GLCXRVCCSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 239000002638 heterogeneous catalyst Substances 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Claims (5)
1. Proces til fremstilling af 100 gram eller mere af en forbindelse af formel IVa:
(IVa) fra en forbindelse af formel Illa:
(ffla) hvor: R er en ethylgruppe; Y er t-butoxycarbonyl (BOC); og, X er benzyl; hvor processen inkluderer at justere pH'en af et reaktionsmedium omfattende en forbindelse af formel Ilia til 2,0-5,0 ved at tilsætte eddikesyre, og at udføre en hydrogenolyse af X under anvendelse af en våd palladium-katalysator.
2. Proces ifølge krav 1, hvor katalysatoren er palladium på carbon med en palladiumindhold på 1-10 %.
3. Proces ifølge et hvilket som helst af kravene 1 eller 2, hvor reaktionsmediet yderligere omfatter et solvent.
4. Proces ifølge krav 3, hvor solventet er ethanol.
5. Proces ifølge et hvilket som helst af kravene 1 til 4, hvor pH'en justeres til 2,5-3,5.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161450177P | 2011-03-08 | 2011-03-08 | |
| PCT/EP2012/053867 WO2012120025A1 (en) | 2011-03-08 | 2012-03-07 | Preparation of a 1-amino-3-hydroxy-cyclobutane-1-carboxylic acid derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2683684T3 true DK2683684T3 (da) | 2018-02-05 |
Family
ID=45808953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12707320.3T DK2683684T3 (da) | 2011-03-08 | 2012-03-07 | Fremstilling af et 1-amino-3-hydroxy-cyclobutan-1-carboxylsyrederivat |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9242924B2 (da) |
| EP (1) | EP2683684B1 (da) |
| JP (1) | JP5938422B2 (da) |
| KR (1) | KR101904565B1 (da) |
| CN (1) | CN103415503B (da) |
| AU (1) | AU2012224634B2 (da) |
| BR (1) | BR112013020627B1 (da) |
| CA (1) | CA2828975C (da) |
| DK (1) | DK2683684T3 (da) |
| ES (1) | ES2657894T3 (da) |
| MX (1) | MX341089B (da) |
| NO (1) | NO2683684T3 (da) |
| RU (1) | RU2596829C2 (da) |
| WO (1) | WO2012120025A1 (da) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000066579A1 (fr) | 1999-04-28 | 2000-11-09 | Banyu Pharmaceutical Co., Ltd. | Methodes de preparation de derives de piperidylmethylpyridine |
| JP4744163B2 (ja) * | 2005-02-28 | 2011-08-10 | 広栄化学工業株式会社 | ビピリジン類の製造方法 |
| TW200736203A (en) | 2005-11-18 | 2007-10-01 | Glaxo Group Ltd | New pleuromutilin derivative and its use |
| BRPI0619213B8 (pt) * | 2005-11-29 | 2021-07-27 | Nihon Mediphysics Co Ltd | composto precursor de composto orgânico marcado com haloênio radioativo |
| CN101573330B (zh) * | 2006-12-27 | 2015-04-08 | 日本医事物理股份有限公司 | 放射性卤素标记的有机化合物的前体化合物的制备方法 |
| CN102026999B (zh) * | 2008-03-11 | 2014-03-05 | 因塞特公司 | 作为jak抑制剂的氮杂环丁烷和环丁烷衍生物 |
| US8741259B2 (en) | 2008-10-20 | 2014-06-03 | Marvin C. Gershengorn | Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists |
| CA2767478A1 (en) | 2009-07-11 | 2011-01-20 | Bayer Pharma Aktiengesellschaft | Radiolabelling method using cycloalkyl groups |
-
2012
- 2012-03-07 DK DK12707320.3T patent/DK2683684T3/da active
- 2012-03-07 NO NO12707320A patent/NO2683684T3/no unknown
- 2012-03-07 ES ES12707320.3T patent/ES2657894T3/es active Active
- 2012-03-07 US US14/002,184 patent/US9242924B2/en active Active
- 2012-03-07 CN CN201280012007.4A patent/CN103415503B/zh active Active
- 2012-03-07 RU RU2013139061/04A patent/RU2596829C2/ru active
- 2012-03-07 EP EP12707320.3A patent/EP2683684B1/en active Active
- 2012-03-07 MX MX2013010254A patent/MX341089B/es active IP Right Grant
- 2012-03-07 CA CA2828975A patent/CA2828975C/en active Active
- 2012-03-07 JP JP2013557076A patent/JP5938422B2/ja active Active
- 2012-03-07 KR KR1020137023602A patent/KR101904565B1/ko active IP Right Grant
- 2012-03-07 AU AU2012224634A patent/AU2012224634B2/en active Active
- 2012-03-07 BR BR112013020627A patent/BR112013020627B1/pt active IP Right Grant
- 2012-03-07 WO PCT/EP2012/053867 patent/WO2012120025A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP2683684A1 (en) | 2014-01-15 |
| KR20140049975A (ko) | 2014-04-28 |
| MX341089B (es) | 2016-08-08 |
| CN103415503A (zh) | 2013-11-27 |
| JP5938422B2 (ja) | 2016-06-22 |
| CA2828975C (en) | 2019-07-09 |
| RU2596829C2 (ru) | 2016-09-10 |
| US20130345468A1 (en) | 2013-12-26 |
| JP2014514268A (ja) | 2014-06-19 |
| EP2683684B1 (en) | 2018-01-03 |
| NO2683684T3 (da) | 2018-06-02 |
| CA2828975A1 (en) | 2012-09-13 |
| RU2013139061A (ru) | 2015-04-20 |
| BR112013020627A2 (pt) | 2016-10-04 |
| CN103415503B (zh) | 2015-09-16 |
| ES2657894T3 (es) | 2018-03-07 |
| US9242924B2 (en) | 2016-01-26 |
| WO2012120025A1 (en) | 2012-09-13 |
| BR112013020627B1 (pt) | 2019-12-03 |
| KR101904565B1 (ko) | 2018-10-04 |
| MX2013010254A (es) | 2013-11-18 |
| AU2012224634B2 (en) | 2016-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2709558C (en) | Process for production of radioactive-fluorine-labeled organic compound | |
| WO2007132689A1 (ja) | 放射性フッ素標識有機化合物の製造方法 | |
| EP2993171A1 (en) | Method for the production of 18F-labeled PSMA-specific PET-tracers | |
| DK2683684T3 (da) | Fremstilling af et 1-amino-3-hydroxy-cyclobutan-1-carboxylsyrederivat | |
| US6919475B2 (en) | Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine | |
| EP2646411B1 (en) | Preparation of pet precursor | |
| AU2012224634A1 (en) | Preparation of a 1-amino-3-hydroxy-cyclobutane-1-carboxylic acid derivative | |
| ES2546997T3 (es) | Preparación de un precursor para PET | |
| US20100150835A1 (en) | Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate | |
| Gomzina et al. | Methylation as a method for synthesis of radiopharmaceuticals for positron emission tomography | |
| BE1024388B1 (fr) | Procede pour la preparation d'analogues de nitroimidazole a base de nucleoside radiomarques | |
| KR101592291B1 (ko) | 고순도 및 고비방사능의 [18f]플루오로-l-도파의 제조 방법 | |
| Castillo | Radiosynthesis of [18 F] fluorophenyl-L-amino acids by isotopic exchange on carbonyl-activated precursors | |
| JP2016011263A (ja) | 放射性標識化合物 |